PI3K pathway regulates ER-dependent transcription in breast cancer through the epigenetic regulator KMT2D.

MLA

Toska, Eneda, et al. “PI3K Pathway Regulates ER-Dependent Transcription in Breast Cancer through the Epigenetic Regulator KMT2D.” Science (New York, N.Y.), vol. 355, no. 6331, Mar. 2017, pp. 1324–30. EBSCOhost, https://doi.org/10.1126/science.aah6893.

APA

Toska, E., Osmanbeyoglu, H. U., Castel, P., Chan, C., Hendrickson, R. C., Elkabets, M., Dickler, M. N., Scaltriti, M., Leslie, C. S., Armstrong, S. A., & Baselga, J. (2017). PI3K pathway regulates ER-dependent transcription in breast cancer through the epigenetic regulator KMT2D. Science (New York, N.Y.), 355(6331), 1324–1330. https://doi.org/10.1126/science.aah6893

Chicago

Toska, Eneda, Hatice U Osmanbeyoglu, Pau Castel, Carmen Chan, Ronald C Hendrickson, Moshe Elkabets, Maura N Dickler, et al. 2017. “PI3K Pathway Regulates ER-Dependent Transcription in Breast Cancer through the Epigenetic Regulator KMT2D.” Science (New York, N.Y.) 355 (6331): 1324–30. doi:10.1126/science.aah6893.